Compared to survivors who did not meet any MetS criteria, the ALL survivors with at least one MetS risk factor presented significantly higher levels of C-peptide (p = 0.028), leptin (p = 0.003), and PAI-1 (p = 0.034). This evidence concerns the gene SERPINE1 and acute lymphoblastic leukemia.